New Orthostatic Hypotension Treatment Reduces Symptoms Without Causing High Blood PressureTuesday, Apr 11, 2006
A drug traditionally used to treat myasthenia gravis shows potential benefit for reducing symptoms of orthostatic hypotension
without raising blood pressure when people lie down, according to results of a double-blind, controlled clinical trial.
New Orthostatic Hypotension Treatment Reduces Symptoms Without Causing High Blood PressureTuesday, Apr 11, 2006
A drug traditionally used to treat myasthenia gravis shows potential benefit for reducing symptoms of orthostatic hypotension
without raising blood pressure when people lie down, according to results of a double-blind, controlled clinical trial.
Parkinson's Disease Is More Than a Brain DisorderMonday, Sep 4, 2000
For many years, researchers have known that the movement problems associated with Parkinson's disease result from a loss of
neurons that produce a nerve-signaling chemical called dopamine in one part of the brain. A new study suggests that Parkinson's
disease (PD) also affects nerve endings that produce a related chemical, norepinephrine, in the heart. The finding improves
understanding about how Parkinson's disease develops and may lead to a way of predicting the disorder and possibly even preventing
it.
Fact Sheet Study Finds Widespread Sympathetic Nerve Damage in Parkinson's DiseaseMonday, Apr 22, 2002
Parkinson's disease is known to cause damage to a specific region of the brain. A new study led by NINDS scientist David
S. Goldstein, M.D., Ph.D., shows that the disease also causes widespread damage to the sympathetic nervous system, which controls
blood pressure, pulse rate, and many other automatic responses to stress. The study also shows that this damage is unrelated
to treatment with the most commonly used Parkinson's drug, levodopa, and may lead to new approaches to identifying the cause
of the disease. The study appears in the April 23, 2002, issue of Neurology.
Fact Sheet Parkinson's Disease Is More Than a Brain DisorderMonday, Sep 4, 2000
For many years, researchers have known that the movement problems associated with Parkinson's disease result from a loss of
neurons that produce a nerve-signaling chemical called dopamine in one part of the brain. A new study suggests that Parkinson's
disease (PD) also affects nerve endings that produce a related chemical, norepinephrine, in the heart. The finding improves
understanding about how Parkinson's disease develops and may lead to a way of predicting the disorder and possibly even preventing
it.
Fact Sheet